Literature DB >> 21314431

Myocardial remodeling: cellular and extracellular events and targets.

Jennifer A Dixon1, Francis G Spinale.   

Abstract

The focus of this review is on translational studies utilizing large-animal models and clinical studies that provide fundamental insight into cellular and extracellular pathways contributing to post-myocardial infarction (MI) left ventricle (LV) remodeling. Specifically, both large-animal and clinical studies have examined the potential role of endogenous and exogenous stem cells to alter the course of LV remodeling. Interestingly, there have been alterations in LV remodeling with stem cell treatment despite a lack of long-term cell engraftment. The translation of the full potential of stem cell treatments to clinical studies has yet to be realized. The modulation of proteolytic pathways that contribute to the post-MI remodeling process has also been examined. On the basis of recent large-animal studies, there appears to be a relationship between stem cell treatment post-MI and the modification of proteolytic pathways, generating the hypothesis that stem cells leave an echo effect that moderates LV remodeling.

Entities:  

Mesh:

Year:  2011        PMID: 21314431      PMCID: PMC3157311          DOI: 10.1146/annurev-physiol-012110-142230

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  136 in total

1.  Clinical practice and future needs in recombinant human granulocyte colony-stimulating factor treatment: a review of randomized trials in clinical haemato-oncology.

Authors:  H E Johnsen
Journal:  J Int Med Res       Date:  2001 Mar-Apr       Impact factor: 1.671

2.  Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.

Authors:  Reiko Nakaya; Hiroyasu Uzui; Hiromasa Shimizu; Akira Nakano; Yasuhiko Mitsuke; Taketoshi Yamazaki; Takanori Ueda; Jong-Dae Lee
Journal:  Int J Cardiol       Date:  2005-10-20       Impact factor: 4.164

3.  Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.

Authors:  H F Bigg; Y E Shi; Y E Liu; B Steffensen; C M Overall
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

4.  Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI).

Authors:  Hüseyin Ince; Michael Petzsch; Hans Dieter Kleine; Heike Schmidt; Tim Rehders; Thomas Körber; Carl Schümichen; Mathias Freund; Christoph A Nienaber
Journal:  Circulation       Date:  2005-11-07       Impact factor: 29.690

5.  Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models.

Authors:  B I Jugdutt; M J Joljart; M I Khan
Journal:  Circulation       Date:  1996-07-01       Impact factor: 29.690

6.  Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction.

Authors:  Toshiro Matsunaga; Naoki Abe; Kunihiko Kameda; Jhoji Hagii; Norio Fujita; Hiroyuki Onodera; Takaatsu Kamata; Hiroshi Ishizaka; Hiroyuki Hanada; Tomohiro Osanai; Ken Okumura
Journal:  Int J Cardiol       Date:  2005-11-02       Impact factor: 4.164

7.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

8.  Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction.

Authors:  S Hirohata; S Kusachi; M Murakami; T Murakami; I Sano; T Watanabe; I Komatsubara; J Kondo; T Tsuji
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

9.  Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia.

Authors:  S Fuchs; R Baffour; Y F Zhou; M Shou; A Pierre; F O Tio; N J Weissman; M B Leon; S E Epstein; R Kornowski
Journal:  J Am Coll Cardiol       Date:  2001-05       Impact factor: 24.094

10.  Myocyte proliferation in end-stage cardiac failure in humans.

Authors:  J Kajstura; A Leri; N Finato; C Di Loreto; C A Beltrami; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more
  15 in total

1.  Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.

Authors:  Michael R Zile; Catalin F Baicu; Robert E Stroud; An Van Laer; Jazmine Arroyo; Rupak Mukherjee; Jeffrey A Jones; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

2.  Diversity of myocardial interstitial proteolytic pathways: gene deletion reveals unexpected consequences.

Authors:  Francis G Spinale
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 3.  The history of matrix metalloproteinases: milestones, myths, and misperceptions.

Authors:  Rugmani Padmanabhan Iyer; Nicolle L Patterson; Gregg B Fields; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

4.  Proteomic analysis of the left ventricle post-myocardial infarction to identify in vivo candidate matrix metalloproteinase substrates.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Lisandra E de Castro Brás; Kevin Hakala; Susan T Weintraub; Merry L Lindsey
Journal:  Methods Mol Biol       Date:  2013

Review 5.  Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI.

Authors:  Edward Danson; Peter Hansen; Sayan Sen; Justin Davies; Ian Meredith; Ravinay Bhindi
Journal:  Nat Rev Cardiol       Date:  2016-02-11       Impact factor: 32.419

Review 6.  Localized targeting of biomaterials following myocardial infarction: a foundation to build on.

Authors:  James A Shuman; Jonathan R Zurcher; Ashley A Sapp; Jason A Burdick; Robert C Gorman; Joseph H Gorman; Edie C Goldsmith; Francis G Spinale
Journal:  Trends Cardiovasc Med       Date:  2013-06-06       Impact factor: 6.677

Review 7.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

8.  Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.

Authors:  Fu Sang Luk; Roy Y Kim; Kang Li; Daniel Ching; David K Wong; Sunil K Joshi; Isabella Imhof; Norman Honbo; Holly Hoover; Bo-Qing Zhu; David H Lovett; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

9.  Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice.

Authors:  Lichan Tao; Sutong Shen; Siyi Fu; Hongyi Fang; Xiuzhi Wang; Saumya Das; Joost P G Sluijter; Anthony Rosenzweig; Yonglan Zhou; Xiangqing Kong; Junjie Xiao; Xinli Li
Journal:  Sci Rep       Date:  2015-02-11       Impact factor: 4.379

10.  The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy.

Authors:  Hui Pang; Bing Han; Tao Yu; Zhen Peng
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.